140 related articles for article (PubMed ID: 20122546)
1. Safety and efficacy of clopidogrel treatment in Japanese patients undergoing drug-eluting stent implantation.
Hayashi F; Iijima R; Nakamura M; Sugi K
J Cardiol; 2010 Jan; 55(1):34-40. PubMed ID: 20122546
[TBL] [Abstract][Full Text] [Related]
2. Clopidogrel for prevention of major cardiac events after coronary stent implantation: 30-day and 6-month results in patients with smaller stents.
Calver AL; Blows LJ; Harmer S; Dawkins KD; Gray HH; Morgan JH; Simpson IA
Am Heart J; 2000 Sep; 140(3):483-91. PubMed ID: 10966552
[TBL] [Abstract][Full Text] [Related]
3. A high maintenance dose of clopidogrel improves short-term clinical outcomes in patients with acute coronary syndrome undergoing drug-eluting stent implantation.
Han YL; Wang B; Li Y; Xu K; Wang SL; Jing QM; Wang ZL; Wang DM; Ma YY; Wang G
Chin Med J (Engl); 2009 Apr; 122(7):793-7. PubMed ID: 19493391
[TBL] [Abstract][Full Text] [Related]
4. Impact of "nuisance" bleeding on clopidogrel compliance in patients undergoing intracoronary drug-eluting stent implantation.
Roy P; Bonello L; Torguson R; de Labriolle A; Lemesle G; Slottow TL; Steinberg DH; Kaneshige K; Xue Z; Satler LF; Kent KM; Suddath WO; Pichard AD; Lindsay J; Waksman R
Am J Cardiol; 2008 Dec; 102(12):1614-7. PubMed ID: 19064014
[TBL] [Abstract][Full Text] [Related]
5. Effect of prasugrel versus clopidogrel on outcomes among patients with acute coronary syndrome undergoing percutaneous coronary intervention without stent implantation: a TRial to assess Improvement in Therapeutic Outcomes by optimizing platelet inhibitioN with prasugrel (TRITON)-Thrombolysis in Myocardial Infarction (TIMI) 38 substudy.
Pride YB; Wiviott SD; Buros JL; Zorkun C; Tariq MU; Antman EM; Braunwald E; Gibson CM;
Am Heart J; 2009 Sep; 158(3):e21-6. PubMed ID: 19699846
[TBL] [Abstract][Full Text] [Related]
6. Aspirin and clopidogrel with or without phenprocoumon after drug eluting coronary stent placement in patients on chronic oral anticoagulation.
Sarafoff N; Ndrepepa G; Mehilli J; Dörrler K; Schulz S; Iijima R; Byrne R; Schömig A; Kastrati A
J Intern Med; 2008 Nov; 264(5):472-80. PubMed ID: 18624903
[TBL] [Abstract][Full Text] [Related]
7. Clopidogrel use and clinical events after drug-eluting stent implantation: findings from the HealthCore Integrated Research Database.
Petersen JL; Barron JJ; Hammill BG; Cziraky MJ; Anstrom KJ; Wahl PM; Eisenstein EL; Krucoff MW; Califf RM; Schulman KA; Curtis LH
Am Heart J; 2010 Mar; 159(3):462-470.e1. PubMed ID: 20211310
[TBL] [Abstract][Full Text] [Related]
8. Use of and inhospital outcomes after early clopidogrel therapy in patients not undergoing an early invasive strategy for treatment of non-ST-segment elevation myocardial infarction: results from Can Rapid risk stratification of Unstable angina patients Suppress ADverse outcomes with Early implementation of the American College of Cardiology/American Heart Association guidelines (CRUSADE).
Alexander D; Ou FS; Roe MT; Pollack CV; Ohman EM; Cannon CP; Gibler WB; Fintel DJ; Peterson ED; Brown DL;
Am Heart J; 2008 Sep; 156(3):606-12. PubMed ID: 18760147
[TBL] [Abstract][Full Text] [Related]
9. Increased long term rates of stent thrombosis and mortality in patients given clopidogrel as compared to ticlopidine following coronary stent implantation.
Wolak A; Amit G; Cafri C; Gilutz H; Ilia R; Zahger D
Int J Cardiol; 2005 Sep; 103(3):293-7. PubMed ID: 16098392
[TBL] [Abstract][Full Text] [Related]
10. Delays in filling clopidogrel prescription after hospital discharge and adverse outcomes after drug-eluting stent implantation: implications for transitions of care.
Ho PM; Tsai TT; Maddox TM; Powers JD; Carroll NM; Jackevicius C; Go AS; Margolis KL; DeFor TA; Rumsfeld JS; Magid DJ
Circ Cardiovasc Qual Outcomes; 2010 May; 3(3):261-6. PubMed ID: 20407117
[TBL] [Abstract][Full Text] [Related]
11. Safety and efficacy evaluation of clopidogrel compared to ticlopidine after stent implantation: an updated meta-analysis.
Casella G; Ottani F; Pavesi PC; Sangiorgio P; Rubboli A; Galvani M; Fontanelli A; Bracchetti D
Ital Heart J; 2003 Oct; 4(10):677-84. PubMed ID: 14664280
[TBL] [Abstract][Full Text] [Related]
12. Impact of clopidogrel resistance on thrombotic events after percutaneous coronary intervention with drug-eluting stent.
Wang ZJ; Zhou YJ; Liu YY; Yu M; Shi DM; Zhao YX; Guo YH; Cheng WJ; Jia de A; Cao Z; Nie B; Ge HL; Yang SW; Yan ZX
Thromb Res; 2009 May; 124(1):46-51. PubMed ID: 19041120
[TBL] [Abstract][Full Text] [Related]
13. Long-term outcomes in patients undergoing coronary stenting on dual oral antiplatelet treatment requiring oral anticoagulant therapy.
Rossini R; Musumeci G; Lettieri C; Molfese M; Mihalcsik L; Mantovani P; Sirbu V; Bass TA; Della Rovere F; Gavazzi A; Angiolillo DJ
Am J Cardiol; 2008 Dec; 102(12):1618-23. PubMed ID: 19064015
[TBL] [Abstract][Full Text] [Related]
14. Safety and efficacy of aspirin, clopidogrel, and warfarin after coronary stent placement in patients with an indication for anticoagulation.
Orford JL; Fasseas P; Melby S; Burger K; Steinhubl SR; Holmes DR; Berger PB
Am Heart J; 2004 Mar; 147(3):463-7. PubMed ID: 14999195
[TBL] [Abstract][Full Text] [Related]
15. Long-term outcomes by clopidogrel duration and stent type in a diabetic population with de novo coronary artery lesions.
Brar SS; Kim J; Brar SK; Zadegan R; Ree M; Liu IL; Mansukhani P; Aharonian V; Hyett R; Shen AY
J Am Coll Cardiol; 2008 Jun; 51(23):2220-7. PubMed ID: 18534267
[TBL] [Abstract][Full Text] [Related]
16. The efficacy and safety of short- and long-term dual antiplatelet therapy in patients with mild or moderate chronic kidney disease: results from the Clopidogrel for the Reduction of Events During Observation (CREDO) trial.
Best PJ; Steinhubl SR; Berger PB; Dasgupta A; Brennan DM; Szczech LA; Califf RM; Topol EJ;
Am Heart J; 2008 Apr; 155(4):687-93. PubMed ID: 18371477
[TBL] [Abstract][Full Text] [Related]
17. Temporal relation between Clopidogrel cessation and stent thrombosis after drug-eluting stent implantation.
Roy P; Bonello L; Torguson R; Okabe T; Pinto Slottow TL; Steinberg DH; Kaneshige K; Xue Z; Satler LF; Kent KM; Suddath WO; Pichard AD; Lindsay J; Waksman R
Am J Cardiol; 2009 Mar; 103(6):801-5. PubMed ID: 19268735
[TBL] [Abstract][Full Text] [Related]
18. A randomized comparison of clopidogrel and aspirin versus ticlopidine and aspirin after coronary stent implantation.
Juergens CP; Wong AM; Leung DY; Lowe HC; Lo S; Fernandes C; Newland EF; Hopkins AP
Am Heart J; 2004 Apr; 147(4):E15. PubMed ID: 15077098
[TBL] [Abstract][Full Text] [Related]
19. Increased risk of bleeding in patients on clopidogrel therapy after drug-eluting stents implantation: insights from the HMO Research Network-Stent Registry (HMORN-stent).
Tsai TT; Ho PM; Xu S; Powers JD; Carroll NM; Shetterly SM; Maddox TM; Rumsfeld JS; Margolis K; Go AS; Magid DJ
Circ Cardiovasc Interv; 2010 Jun; 3(3):230-5. PubMed ID: 20442361
[TBL] [Abstract][Full Text] [Related]
20. Effectiveness of two-year clopidogrel + aspirin in abolishing the risk of very late thrombosis after drug-eluting stent implantation (from the TYCOON [two-year ClOpidOgrel need] study).
Tanzilli G; Greco C; Pelliccia F; Pasceri V; Barillà F; Paravati V; Pannitteri G; Gaudio C; Mangieri E
Am J Cardiol; 2009 Nov; 104(10):1357-61. PubMed ID: 19892050
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]